Citywire printed articles sponsored by:
View the article online at http://citywire.co.uk/new-model-adviser/article/a478393
Integrity's Stamp appointed director of life settlement fund
by Iain Martin on Mar 16, 2011 at 10:02
Integrity Financial Solutions chief executive Iain Stamp has taken a new role as a director of a life settlement fund.
The head of Integrity, which was censured by the regulator, is one of the directors of Dublin-based Strategic Life Settlement fund that is open to UK investors through the Huet Capital Life Settlement fund. The Huet Capital fund secured FSA authorisation as a qualified investor scheme last week.
The Huet Capital fund is the first life settlement fund to acquire FSA authorisation after securing qualified investor scheme status last week, meaning it will afford investors Financial Services Compensation Scheme protection.
Huet Capital managing director Christopher Finch said he had every confidence in Stamp and was fully aware of the complaints over his geared traded endowment policy business. ‘We have done due diligence and found Iain to be very open and transparent and totally committed to the life settlement market,’ said Finch.
Iain Stamp said the FSA and the Central Bank of Ireland were aware and approved his involvement in the Strategic Life Settlement fund as a director and a consultant via his Life Settlement Consulting business. ‘The Central Bank of Ireland is fully aware of the Integrity issue and has approved me as executive director of an open ended investment company. All the counterparts that make up the Strategic Life Settlement are fully aware of Integrity and have no issue with me at all,’ he said.
‘We are very proud of the fact we spent five years developing the methodology behind the Strategic Life Settlement fund. We have then had a year of negotiation with the FSA to get the feeder fund authorised which makes it the first in the UK,’ he added. ‘The FSA looked at the Irish fund in great detail and that demonstrates the quality of its structure.’
Stamp said he had spent five years and around $5 million developing the Strategic Life Settlement fund to a benchmark standard for the asset class published by US ratings agency AM Best. US asset managers Vida Capital had invested $10 million of seed capital into the Irish domiciled fund, he added.
Stamp has also acted as a consultant to another life settlement fund, Isle of Man-based Utopia TLP Plc. The fund has been suspended since September 2008 because of difficulties pricing and realising its assets. He unsuccessfully sued the fund in December 2008 through the Manx High Court to enforce a contract which would have meant up to 3% commission on the life settlement policies purchased by Utopia would have been paid to Integrity.
He said he had warned Utopia that its domicile and investment strategy would lead to failure and had sued over work that he had not been paid for. ‘We advised the Utopia fund to change the way it was structured…Utopia terminated the advisory agreement because they did not like what we advised them. We actually sued for damages because they owed us a whole load of money and we lost the case for technical reasons.’
Stamp also acts a director of a $1.9 billion life settlement securitisation, Life Asset Trust SA, based in Luxembourg. He continues to contest the FSA decision to censure Integrity for poor sales practices when advising clients and unclear marketing material as an product provider.
Markets
News sponsored by:
Today's top headlines
iShares: Time to shatter the ETF myths
As result of industry changes - the retail distribution review - and a growing focus on cost-efficient solutions, we anticipate the number of investors using ETFs will rise significantly over the coming years.
But as with any newer product, especially in the financial world, various misconceptions about ETFs have perpetuated over the years and iShares is committed to addressing and ultimately dispelling these.
More about this article:
More from us
- London Capital reveals potential £7.7m liability to complaints
- Integrity investors seek compensation from lenders
- Integrity investors complain to FOS over London Capital
- Integrity investors complain to FOS over London Capital
- A2O network member goes into liquidation with £1m of client cash in Integrity
- A2O claims mount with £150k Integrity case
- Adviser Week: Advisers face £66m bill after Integrity default
- Fatchett accuses Mint of stalling over £3m Integrity compensation
- Integrity shifts blame to networks over GTEPs
- Advice on Integrity products led to Garrison FSA censure
- Ex-Integrity head Iain Stamp heads to Italy to present on currency trading
- Integrity's Stamp clashes with critics in court
- FSA censures Integrity but waives £350,000 fine
- Integrity offered advisers up to 14% commission
- Integrity scandal: how Maximiser was marketed to advisers
What others are saying
Archive
Read more...
FCA urged to clarify platform promotion rules
by Michelle Abrego on Jun 19, 2013 at 15:33





2 comments so far. Why not have your say?
Jonathan Halsey
Mar 16, 2011 at 11:26
GEN 1.2 Referring to approval by the FSA
GEN 1.2.1 Guidance21/06/2001
The purpose of GEN 1.2.2 R is to prevent clients being misled about the extent to which the FSA has approved a firm's affairs.
GEN 1.2.2 Rule01/11/2007
(1) Unless required to do so under the regulatory system, a firm must ensure that neither it nor anyone acting on its behalf claims, in a public statement or to a client, expressly or by implication, that its affairs, or any aspect of them, have the approval or endorsement 1of the FSA or another competent authority1.
(2) Paragraph (1) does not apply to statements that explain, in a way that is fair, clear and not misleading, that:
(a) the firm is an authorised person;
(b) the firm has permission to carry on a specific activity;
(c) an authorisation order has been made in relation to an AUT or ICVC;
(d) a recognised scheme has that status;
(e) the firm's approved persons have been approved by the FSA for the purposes of section 59 of the Act (Approval for particular arrangements);
(f) the firm has been given express written approval by the FSA in respect of a specific aspect of the firm's affairs.
(3) Paragraph (1) applies with respect to the carrying on of both regulated activities and unregulated activities.
GEN 1.2.3 Guidance01/01/2006
GEN 1.2.2 R (2)(f)2 is confined to written approval because of the need for clarity as to the scope of any approval given by the FSA.
report thisNo one in particular
Mar 17, 2011 at 18:09
With a minimum investment of USD1 million, isn't this a big ticket or institutional fund? And I doubt the FSCS cover would do you any good if it does actually qualify.
report thisleave a comment
Please sign in here or register here to comment. It is free to register and only takes a minute or two.